Skip to main content

Terry Dubrow Took a Lie Detector Test to Launch HealthRX.com. It Caught Him Lying

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

SHERIDAN, WY / ACCESS Newswire / November 12, 2026 / Dr. Terry Dubrow launched HealthRX.com today as founder and chief medical officer of the new telehealth company. To do it, he sat in a white coat with a blood pressure cuff on his arm and polygraph straps across his chest, and let an examiner ask him 23 questions on camera.

Dr. Terry Dubrow connected to a polygraph for the HealthRX.com launch.

HealthRX.com gives patients online access to independent licensed clinicians for GLP-1 and prescription peptide care. Its launch film opens with Dubrow saying, "Don't trust me. I'm a doctor."

The polygraph flags him more than once.

Question: Have you ever been self-conscious about your own weight? Dubrow: "No." A red X fills the examiner's screen. Then the real answer: "I've been a yo-yo dieter my entire life. I've been victimized by what I call my own personal food noise. Even when I've eaten and I'm full, there's still something driving me to eat more."

Dr. Terry Dubrow, founder and chief medical officer of HealthRX.com.

Question: Have you personally taken a GLP-1? Dubrow: "No." Another red X. "Of course I've taken a GLP-1 drug," he says. "I love them. I wouldn't be here partnering with HealthRX if it weren't for my positive experience with GLP-1 drugs."

Most of his other answers register as true, including the ones a new company might prefer to skip.

Question: Should people trust you? Dubrow: "Yes, but not blindly."

Question: Would you tell someone not to take a GLP-1 even if it meant HealthRX lost a customer? Dubrow: "Oh yes."

Question: Would you recommend HealthRX to someone you love if they were medically eligible? Dubrow: "I would definitely recommend HealthRX to someone I love if they were medically eligible."

Question: Has your wife Heather ever told you that you're too obsessed with GLP-1s? Dubrow: "Yes." He adds, "Heather will tell you, don't get him started. It's his favorite topic."

The polygraph is the film's device for a serious point, which is that patients should question anyone selling prescription medication online. HealthRX.com does not present it as proof of any medical claim. The campaign line is "Don't trust us. Test us."

HealthRX.com works like this. A patient answers questions online about their health and medical history. An independent licensed clinician reviews the answers and decides which treatment, if any, is appropriate. If a treatment is prescribed, it ships to the patient's door, and the care team stays available for questions and adjustments. Completing the assessment does not guarantee a prescription.

The launch comes two weeks after HHS announced a conditional peptide-compounding policy. On Oct. 28, the U.S. Department of Health and Human Services announced an interim enforcement-discretion policy covering six peptide bulk drug substances, subject to specified conditions while FDA develops its 503A bulks list through rulemaking. HealthRX.com offers prescription care involving those six, with treatment subject to a clinician's review. The policy is not FDA approval, and compounded medications are not FDA approved.

Dubrow is a board-certified plastic surgeon and has been certified by the American Board of Obesity Medicine since December 2024.

The launch video and the online assessment are at https://healthrx.com.

About HealthRX.com

HealthRX.com is a U.S. telehealth brand launching with Dr. Terry Dubrow as founder and chief medical officer. The platform facilitates online access to independent licensed clinicians for GLP-1 and prescription peptide care. Treatment is prescribed when clinically appropriate, with delivery and continuing access to care-team support. Learn more at https://healthrx.com.

Media contact

Jennifer Washburn | HealthRX.com | press@healthrx.com

SOURCE: HealthRXcom LLC



View the original press release on ACCESS Newswire

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

Recent Quotes

View More
Symbol Price Change (%)
AMZN  267.44
+1.27 (0.48%)
AAPL  354.88
-0.75 (-0.21%)
AMD  585.30
+32.40 (5.86%)
BAC  50.51
-0.16 (-0.32%)
GOOG  295.35
+4.72 (1.62%)
META  623.61
-5.16 (-0.82%)
MSFT  523.00
+1.88 (0.36%)
NVDA  166.19
-7.54 (-4.34%)
ORCL  127.11
-1.27 (-0.99%)
TSLA  397.45
+6.61 (1.69%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.